Eli Lilly Stock Drops After Earnings. Its Guidance Disappoints.
Lilly cuts its guidance for full-year earnings to a range of $6.50 to $6.70 a share, having raised its outlook in August to a range of $9.70 to $9.90.
Source: marketwatch.com
Page 8 - Davida Ricks News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Davida Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Davida Ricks Today - Breaking & Trending Today
Eli Lilly and Co (LLY) Q3 2023 Earnings: 37% Revenue Growth and Business Development Activity
Strong sales growth driven by Mounjaro, Verzenio, and Jardiance
Source: yahoo.com
GLP-1 drugs carry Lilly, Novo; Moderna tops revenue expectations
In addition to Eli Lilly, Novo Nordisk and Moderna, Regeneron also produced its latest quarterly earnings report Thursday morning.
Source: mmm-online.com
Indiana's new federal Tech Hub designation is met with bipartisan celebration
This week, the U.S. Department of Commerce’s Economic Development Administration announced that Indiana-based Heartland BioWorks, a consortium led by the Applied Research Institute, has been designated as a Regional Technology
Source: thestatehousefile.com
Eli Lilly reorganizes leadership team, names new head of diabetes
Succeeding Mike Mason on January 1, 2024 will be company veteran Patrik Jonsson, who currently serves as EVP and president of Lilly USA.
Source: mmm-online.com